Signaturefd LLC boosted its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 10.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 23,992 shares of the biopharmaceutical company’s stock after purchasing an additional 2,249 shares during the quarter. Signaturefd LLC’s holdings in Gilead […]